Article Notes
- Do not routinely reverse muscle relaxants (65% and 82% respectively US & EU).
- Do not have access to quantitative NMBD monitors (77% and 30%).
- Do not ever use neuromuscular monitors (9% and 19%).
This 2010 survey found that a significant proportion of both American anesthesiologists and European anaesthetists:
Debaene et al. investigated residual paralysis in the PACU after a single intubating dose of intermediate NMBD in the absence of reversal.
They identified PORC (Post-Operative Residual Curarization = TOFR <0.9) in 45% of patients, with 'time since NMBD' ranging from 30 to 400 minutes.
In a subgroup of patients 2 hours after a single NMBD dose there was still a 37% incidence of PORC.
Additionally there was very wide inter-patient variability, with PORC persisting more than 6 hours in three patients, and several patients with TOFR of only 0.2 after 2 hours.
In 83 patients researchers compared intubation with propofol 1.5 mg/kg, remifentanil 0.30 μg/kg/min & sevoflurane 1.0 MAC to intubation with the same propofol & remifentanil dose, along with rocuronium 0.45 mg/kg.
Acceptable intubating conditions were 18% more frequent in the muscle relaxant group than in those receiving propofol/remi/sevo.
Incidence of laryngeal injury, hoarseness and sore throat was similar between the two groups - which is different to the result from an earlier, larger study of intubation without relaxant: Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort.